Publications
Securities Class Actions in the Life Sciences Sector
Spring 2025
Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2024.
In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 49 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2024.
Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.
Knowledge Management Lawyer Zarine Alam also contributed to the 2024 annual report.
Contacts
Capabilities
Suggested News & Insights
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Represents Sheridan Capital Partners in Its Investment in PtEverywhereSeptember 22, 2026Sidley Represents Underwriters in Connection With GSK’s US$6.5 Billion Senior Notes OfferingSeptember 22, 2026EU Biotech Act I: Parliament and Council back Europe’s biotech competitiveness agenda – SPC incentive now the key battlegroundSeptember 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory